2,325 Shares in Danaher Corporation $DHR Bought by Saturna Capital Corp

Saturna Capital Corp acquired a new stake in shares of Danaher Corporation (NYSE:DHR) during the 2nd quarter, HoldingsChannel reports. The fund acquired 2,325 shares of the conglomerate’s stock, valued at approximately $459,000.

A number of other institutional investors and hedge funds have also modified their holdings of DHR. Red Tortoise LLC boosted its holdings in Danaher by 175.0% in the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after buying an additional 98 shares during the last quarter. Costello Asset Management INC purchased a new position in shares of Danaher in the first quarter valued at approximately $41,000. Ramirez Asset Management Inc. acquired a new stake in shares of Danaher in the second quarter worth approximately $40,000. Strengthening Families & Communities LLC increased its position in shares of Danaher by 81.4% during the first quarter. Strengthening Families & Communities LLC now owns 254 shares of the conglomerate’s stock worth $52,000 after purchasing an additional 114 shares in the last quarter. Finally, Saudi Central Bank acquired a new position in Danaher in the 1st quarter valued at $52,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have issued reports on DHR shares. Cowen reaffirmed a “buy” rating on shares of Danaher in a research note on Wednesday, October 22nd. JPMorgan Chase & Co. boosted their price target on shares of Danaher from $260.00 to $270.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. TD Cowen increased their price objective on shares of Danaher from $250.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Robert W. Baird set a $247.00 target price on Danaher in a report on Wednesday, October 22nd. Finally, Wall Street Zen lowered Danaher from a “buy” rating to a “hold” rating in a research report on Monday, November 10th. Eighteen research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $243.39.

Insider Buying and Selling at Danaher

In other news, SVP Brian W. Ellis sold 21,776 shares of the company’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the transaction, the senior vice president owned 14,553 shares of the company’s stock, valued at $3,190,454.19. This represents a 59.94% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Georgeann Couchara sold 5,174 shares of the stock in a transaction on Monday, November 10th. The stock was sold at an average price of $210.42, for a total value of $1,088,713.08. Following the transaction, the senior vice president owned 2,625 shares of the company’s stock, valued at approximately $552,352.50. This represents a 66.34% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 29,728 shares of company stock worth $6,448,990 over the last quarter. 11.10% of the stock is currently owned by company insiders.

Danaher Stock Performance

NYSE:DHR opened at $225.75 on Wednesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. The firm has a market capitalization of $159.46 billion, a price-to-earnings ratio of 46.55, a PEG ratio of 3.28 and a beta of 0.81. The company’s 50-day moving average is $206.70 and its two-hundred day moving average is $201.47. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $258.23.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. The business had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The business’s revenue was up 4.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.71 EPS. Analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, October 31st. Shareholders of record on Friday, September 26th were given a $0.32 dividend. The ex-dividend date was Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s payout ratio is currently 26.39%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.